Related posts
Hot Meta, hot jobs reportTSX flat, Wall Street declines on hot employment numbersTSX rises, Wall St. mixedThis summary was created by AI, based on 1 opinions in the last 12 months.
The reviews for Clorox Company (CLX-N) suggest that the stock is considered expensive with a high price-to-earnings ratio for a consumer product. The company's slow growth and weak balance sheet, attributed to a significant amount of debt, are areas of concern. However, it is acknowledged that the company is fairly well managed, although cost-cutting efforts can only go so far, warranting caution for potential investors. Overall, the sentiment towards Clorox Company is mixed, with both positive and negative aspects being highlighted by different experts.
Clorox Company is a American stock, trading under the symbol CLX-N on the New York Stock Exchange (CLX). It is usually referred to as NYSE:CLX or CLX-N
In the last year, 1 stock analyst published opinions about CLX-N. 0 analysts recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Clorox Company.
Clorox Company was recommended as a Top Pick by on . Read the latest stock experts ratings for Clorox Company.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
1 stock analyst on Stockchase covered Clorox Company In the last year. It is a trending stock that is worth watching.
On 2024-03-27, Clorox Company (CLX-N) stock closed at a price of $152.74.
Still really expensive at over 30x earnings for a consumer product. Not fantastic growth. Relatively weak balance sheet, lots of debt. Fairly well managed. Cost-cutting efforts can only go so far. Be careful.